As established by pathological studies, similar to patients with Alzheimer's disease (AD), the brains of diabetes-associated cognitive dysfunction patients are also featured by amyloid deposition and abnormal phosphorylation of tau proteins [22]. The gene discussed is MAPT; the disease is diabetes mellitus.